| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $591.8M | +20.1% |
| Cost of Revenue | $184.3M | +14.6% |
| Gross Profit | $407.5M | +22.8% |
| R&D Expense | $71.5M | +18.6% |
| SG&A Expense | $418.6M | +8.5% |
| Operating Income | -$115.5M | +7.7% |
| Pre-tax Income | -$112.7M | +8.1% |
| Income Tax | $565K | -24.7% |
| Net Income | -$113.3M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $419.6M | +1060.0% |
| Short-term Investments | $116.0M | +18.8% |
| Accounts Receivable | $79.9M | +30.0% |
| Inventory | $14.0M | +0.5% |
| Current Assets | $645.8M | +179.8% |
| Total Assets | $931.4M | +115.0% |
| Current Liabilities | $110.9M | +3.3% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $3.4M | +106.8% |
| Capital Expenditures | $33.9M | -16.0% |
| Investing Cash Flow | -$123.0M | — |
| Financing Cash Flow | $511.4M | +5698.0% |
| Free Cash Flow | -$30.6M | +66.3% |
| +8.2% |
| EPS (Basic) | -$3.63 | +10.1% |
| EPS (Diluted) | -$3.63 | +10.1% |
| Total Liabilities |
| $840.5M |
| +276.8% |
| Stockholders' Equity | $90.9M | -56.7% |